The effect of liver cirrhosis on the pharmacokinetics of phenprocoumon
✍ Scribed by N. R. Kitteringham; L. Büstgens; E. Brundert; S. Mineshita; E. E. Ohnhaus
- Publisher
- Springer
- Year
- 1984
- Tongue
- English
- Weight
- 677 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Recent work has shown that colchicine may benefit patients with primary biliary or alcoholic cirrhosis. However, very little is known about its pharmacokinetics in the presence of impaired liver function. To study this w e examined the effects of three models of experimental liver dysfunction and on
The influence of hepatic disease on the pharmacokinetics of the new ACE inhibitor, benazepril hydrochloride, was evaluated in 12 male patients suffering from liver cirrhosis. The patients received a single oral 20 mg dose. The plasma concentrations and urinary excretion of unchanged benazepril and i
its tissue specificity have been studied intensively in rats. 2 The activities of key enzymes in the valine cata- The first step in BCAA catabolism, which takes place largely bolic pathway -branched-chain aminotransferase, in extrahepatic tissues, is reversible transamination of the branched-chain